Key statistics
On Friday, Amylyx Pharmaceuticals Inc (AMLX:NSQ) closed at 15.17, -13.26% below its 52-week high of 17.49, set on Jan 22, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 15.00 |
|---|---|
| High | 15.45 |
| Low | 14.99 |
| Bid | -- |
| Offer | -- |
| Previous close | 15.26 |
| Average volume | 814.21k |
|---|---|
| Shares outstanding | 109.82m |
| Free float | 93.28m |
| P/E (TTM) | -- |
| Market cap | 1.67bn USD |
| EPS (TTM) | -1.80 USD |
Data delayed at least 15 minutes, as of Feb 27 2026 21:00 GMT.
More ▼
- Amylyx Pharmaceuticals to Participate in Upcoming March Investor Conferences
- Amylyx Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026
- Amylyx Pharmaceuticals Announces Nomination of AMX0318 as a Novel, Long-Acting GLP-1 Receptor Antagonist Development Candidate, Identified in Collaboration with Gubra A/S
- Amylyx Pharmaceuticals Announces New Safety and Tolerability Cohort 1 Data of AMX0114 in ALS from First-in-Human LUMINA Trial
